Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
University of Miami
80 participants
Oct 27, 2021
INTERVENTIONAL
Conditions
Summary
The objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard of care microsurgical clipping of an unruptured cerebral artery aneurysm.
Standard of care endovascular treatment of an unruptured cerebral artery aneurysm.
Daily oral Sirolimus 2 mg tablets, adjusted as necessary per treating physician.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04141020